| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,232 | 17,281 | 15,818 | 17,366 | | Cost of Revenue | 2,428 | 2,966 | 15,489 | 3,575 | | | Gross Profit | 14,804 | 14,315 | 329 | 13,791 | | | Operating Expenses | | Research Development | 8,940 | 9,211 | 10,591 | 10,867 | | Selling General and Administrative | 9,615 | 8,613 | 10,738 | 11,045 | | Non Recurring | 65 | 360 | 34,262 | 93 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,816) | (3,869) | (55,262) | (8,214) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (502) | 335 | 270 | | Earnings Before Interest And Taxes | (3,965) | (4,371) | (54,927) | (7,944) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,965) | (4,371) | (54,927) | (7,944) | | Income Tax Expense | 1,062 | 1,383 | 221 | 1,399 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,027) | (5,754) | (55,148) | (9,343) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,027) | (5,754) | (55,148) | (9,343) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,027) | ($5,754) | ($55,148) | ($9,343) |
|
0.01% Nasdaq 
Income Statement
